Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes
Author:
Affiliation:
1. Diabetes Division, Dept of Medicine, UT Health and Texas Diabetes Institute San Antonio Texas USA
2. University of Chicago School of Medicine, Dept of Medicine Chicago Illinois USA
Funder
Bayer HealthCare
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14696
Reference89 articles.
1. Targeted literature review of the burden of illness in patients with chronic kidney disease and type 2 diabetes;Fried LF;Am J Manag Care,2021
2. KDIGO 2020 clinical practice guideline for diabetes Management in Chronic Kidney Disease;Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group;Kidney Int,2020
3. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non‐steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes;Diabetes, Obesity and Metabolism;2023-10-27
2. The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances;Clinical and Experimental Nephrology;2023-10-17
3. Novel Therapeutic Approaches in the Management of Chronic Kidney Disease;Biomedicines;2023-10-11
4. The Bidirectional Link Between Diabetes and Kidney Disease: Mechanisms and Management;Cureus;2023-09-20
5. Multimodal efforts to slow the progression of chronic kidney disease in patients with type 2 diabetes mellitus;Journal of Diabetes and its Complications;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3